Practice
Featured experience
Truist $15.5 billion sale of remaining stake in Truist Insurance to investor group
We are advising Truist on the transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Instant Brands sale of substantially all of its assets to Centre Lane Partners
We are advising Instant Brands on the sale
TruArc Partners acquisition of Meyer Laboratory and $179 million financing
We advised TruArc Partners on the acquisition and related financing arrangements
SEB $1.75 billion notes offering
The investment-grade notes are due 2027 and 2029
Lightyear Capital strategic investment in Prime Pensions
We advised Lightyear Capital on the transaction and related debt financing
REV Group $289.9 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Delinea acquisition of Fastpath Solutions
We are advising Delinea on the acquisition
Truist $15.5 billion sale of remaining stake in Truist Insurance to investor group
We are advising Truist on the transaction
HireRight $1.65 billion acquisition by General Atlantic and Stone Point Capital
We are advising the special committee of HireRight on the transaction
Cigna $4.5 billion senior notes offering
The senior notes are due 2029, 2031, 2034 and 2054
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition